Press releases
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
- Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
- Puma Biotechnology to Join Russell 3000 Index
- Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
- Puma Biotechnology Reports First Quarter Financial Results
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
More ▼
Key statistics
On Friday, Puma Biotechnology Inc (0PB:BER) closed at 3.21, 54.80% above the 52 week low of 2.08 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.27 |
---|---|
High | 3.32 |
Low | 3.20 |
Bid | 3.14 |
Offer | 3.38 |
Previous close | 3.25 |
Average volume | 3.25k |
---|---|
Shares outstanding | 48.24m |
Free float | 40.81m |
P/E (TTM) | 11.22 |
Market cap | 174.14m USD |
EPS (TTM) | 0.3219 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 19:21 BST.
More ▼